| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 22.3 | 11.1 | +100.9% |
| EBITDA | 0.9 | 1.3 | −28.3% |
| EBITDA margin | 4.3% | 11.9% | −7.7 pts |
| Profit before tax | 1.0 | 1.4 | −26.0% |
| Net profit | 0.8 | 1.0 | −26.0% |
| EPS | ₹0.20 | ₹0.27 | −25.9% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 42.6 | — | — | — | — | |
| 0.2 | 0.2 | 0.4 | 0.8 | 0.6 | |
| 10.1 | 10.1 | 9.5 | 9.7 | 10.1 | |
| 52.6 | — | — | — | — | |
| 89.6 | 78.4 | 65.7 | 50.3 | 50.0 | |
| — | +19.4% | +30.5% | +0.6% | — | |
| 4.6 | 5.0 | 5.6 | 2.5 | 2.0 | |
| 5.1% | 6.4% | 8.5% | 5.0% | 4.0% | |
| 4.4 | 4.8 | 5.3 | 2.2 | 1.7 | |
| 3.6 | 3.9 | 4.1 | 1.0 | 0.7 | |
| 4.0% | 4.9% | 6.2% | 2.0% | 1.3% | |
| ₹0.95 | ₹1.02 | ₹1.08 | ₹0.27 | ₹0.17 | |
| — | −5.6% | +301.0% | +56.3% | — | |
| — | −1.3 | −15.9 | 1.2 | 0.1 | |
| — | −0.1 | −0.1 | −0.0 | 0.0 | |
| −1.4 | −1.4 | −16.0 | 1.2 | 0.1 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 42.6 | |
| - Cash, Equiv & ST Investments | 0.6 | 0.8 | 0.4 | 0.2 | 0.2 | |
| + Total Debt | 10.1 | 9.7 | 9.5 | 10.1 | 10.1 | |
| Enterprise Value | — | — | — | — | 52.6 | |
| Revenue | 50.0 | 50.3 | 65.7 | 78.4 | 89.6 | |
| Growth %, YoY | — | +0.6 | +30.5 | +19.4 | — | |
| EBITDA | 2.0 | 2.5 | 5.6 | 5.0 | 4.6 | |
| Margin % | 4.03 | 5.00 | 8.49 | 6.35 | 5.14 | |
| EBIT | 1.7 | 2.2 | 5.3 | 4.8 | 4.4 | |
| Net Income | 0.7 | 1.0 | 4.1 | 3.9 | 3.6 | |
| Margin % | 1.30 | 2.03 | 6.22 | 4.92 | 4.01 | |
| EPS, Adj (current shares) | 0.17 | 0.27 | 1.08 | 1.02 | 0.95 | |
| Growth %, YoY | — | +56.3 | +301.0 | -5.6 | — | |
| Cash from Operations | 0.1 | 1.2 | -15.9 | -1.3 | — | |
| Capital Expenditures | -0.0 | -0.0 | -0.1 | -0.1 | — | |
| Free Cash Flow | 0.1 | 1.2 | -16.0 | -1.4 | -1.4 | |
Prices at the previous close · figures from the company's filings with NSE
Narmada Agrobase (NSE: NARMADA) had a market capitalisation of ₹42.6 crore at the previous close (₹11.24 a share), a PE ratio of 11.9 on the last four quarters' profit and a price-to-book ratio of 0.72. In FY26 its consolidated net profit was ₹3.9 crore on revenue of ₹78.4 crore; in Q1 FY27 (April–June 2026) it was ₹75 lakh, down 26.0% year on year. Its debt-to-equity ratio was 0.17 on 31 March 2026. Promoters held 50.30% of the shares on 30 September 2026.
Narmada Agrobase's PE ratio is 11.9 at the previous close (₹11.24 a share): a market capitalisation of ₹42.6 crore divided by consolidated net profit of ₹3.6 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹3.9 crore) it is 11.1.
Narmada Agrobase's debt-to-equity ratio was 0.17 on 31 March 2026: borrowings of ₹10.1 crore against total equity of ₹59.3 crore. A year earlier, on 31 March 2025, it was 0.17.
Narmada Agrobase's net worth — shareholders' equity in its consolidated balance sheet — was ₹59.3 crore on 31 March 2026, up 6.2% from ₹55.9 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹42.6 crore at the previous close.
Narmada Agrobase's price-to-book (PB) ratio is 0.72 at the previous close: a market capitalisation of ₹42.6 crore divided by shareholders' equity (book value) of ₹59.3 crore on 31 March 2026. That is a book value of ₹15.64 per share against a share price of ₹11.24.
In FY26, Narmada Agrobase's return on equity (ROE) was 6.7% and its return on capital employed (ROCE) was 8.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 11.2% and ROCE 14.4%.
Narmada Agrobase's book value per share was ₹15.64 on 31 March 2026: shareholders' equity of ₹59.3 crore divided by the 3.79 crore shares in issue, up 6.2% from ₹14.73 a year earlier. The share price at the previous close was ₹11.24.
Narmada Agrobase's market capitalisation was ₹42.6 crore at the previous close: 3.79 crore shares at ₹11.24 each.
Narmada Agrobase's basic earnings per share (EPS) were ₹1.02 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.95.
Narmada Agrobase will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
No. Narmada Agrobase had borrowings of ₹10.1 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.17. Its cash and current investments were ₹10.4 crore, so it held net cash of ₹27 lakh.
Promoters held 50.30% of Narmada Agrobase on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Narmada Agrobase generated ₹1.3 crore of cash from operations and spent ₹15 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹1.4 crore. In FY25 it was −₹16 crore.
On 30 September 2026, Narmada Agrobase's shares were held by promoters 50.30%, foreign portfolio investors (FII/FPI) 0.11%, domestic institutions (DII) 6.50% and retail and other non-institutional investors 43.10%. Over the year, DII holding was down 2.46 percentage points from 8.96%.
Narmada Agrobase's latest results are for Q1 FY27 (April–June 2026), filed on 14 August 2026: consolidated net profit ₹75 lakh, down 26.0% from ₹1 crore in Q1 FY26; revenue from operations ₹22.3 crore, up 100.9% year on year.
On FY26 consolidated figures, against Mukka Proteins and KSE: Narmada Agrobase's operating margin of 6.1% is the lowest of the three (Mukka Proteins 6.8%, KSE 6.9%; peer average 6.9%); its return on equity of 6.7% is the lowest of the three (Mukka Proteins 11.1%, KSE 24.1%; peer average 17.6%).
In FY26 (April 2025–March 2026), Narmada Agrobase's consolidated net profit was ₹3.9 crore, down 5.6% from ₹4.1 crore in FY25, on revenue from operations of ₹78.4 crore (up 19.4%). Over three years, from FY23, net profit was up 491.4%.
In FY26, Narmada Agrobase earned net profit of ₹3.9 crore on revenue of ₹78.4 crore, against ₹52.1 crore on ₹1,449 crore for Mukka Proteins. Narmada Agrobase's operating margin was 6.1% (Mukka Proteins 6.8%) and its return on equity 6.7% (Mukka Proteins 11.1%).
From Narmada Agrobase's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.